Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase.
Filippa N
,
Sable CL
,
Filloux C
,
Hemmings B
,
Van Obberghen E
.
???displayArticle.abstract???
Activation of protein kinase B (PKB) by growth factors and hormones has been demonstrated to proceed via phosphatidylinositol 3-kinase (PI3-kinase). In this report, we show that PKB can also be activated by PKA (cyclic AMP [cAMP]-dependent protein kinase) through a PI3-kinase-independent pathway. Although this activation required phosphorylation of PKB, PKB is not likely to be a physiological substrate of PKA since a mutation in the sole PKA consensus phosphorylation site of PKB did not abolish PKA-induced activation of PKB. In addition, mechanistically, this activation was different from that of growth factors since it did not require phosphorylation of the S473 residue, which is essential for full PKB activation induced by insulin. These data were supported by the fact that mutation of residue S473 of PKB to alanine did not prevent it from being activated by forskolin. Moreover, phosphopeptide maps of overexpressed PKB from COS cells showed differences between insulin- and forskolin-stimulated cells that pointed to distinct activation mechanisms of PKB depending on whether insulin or cAMP was used. We looked at events downstream of PKB and found that PKA activation of PKB led to the phosphorylation and inhibition of glycogen synthase kinase-3 (GSK-3) activity, a known in vivo substrate of PKB. Overexpression of a dominant negative PKB led to the loss of inhibition of GSK-3 in both insulin- and forskolin-treated cells, demonstrating that PKB was responsible for this inhibition in both cases. Finally, we show by confocal microscopy that forskolin, similar to insulin, was able to induce translocation of PKB to the plasma membrane. This process was inhibited by high concentrations of wortmannin (300 nM), suggesting that forskolin-induced PKB movement may require phospholipids, which are probably not generated by class I or class III PI3-kinase. However, high concentrations of wortmannin did not abolish PKB activation, which demonstrates that translocation per se is not important for PKA-induced PKB activation.
Ahmed,
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase.
1997, Pubmed
Ahmed,
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase.
1997,
Pubmed
Alessi,
3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro.
1998,
Pubmed
Alessi,
Mechanism of activation and function of protein kinase B.
1998,
Pubmed
Alessi,
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.
1997,
Pubmed
Andjelković,
Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors.
1996,
Pubmed
Andjelković,
Role of translocation in the activation and function of protein kinase B.
1997,
Pubmed
Bellacosa,
Akt activation by growth factors is a multiple-step process: the role of the PH domain.
1998,
Pubmed
Bellacosa,
A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region.
1991,
Pubmed
Brady,
The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells.
1998,
Pubmed
Burgering,
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.
1995,
Pubmed
Burgering,
cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.
1993,
Pubmed
Cheng,
AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
1992,
Pubmed
Cheng,
Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
1996,
Pubmed
Coffer,
Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families.
1991,
Pubmed
Cong,
Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells.
1997,
Pubmed
Cook,
Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C.
1996,
Pubmed
Cook,
Inhibition by cAMP of Ras-dependent activation of Raf.
1993,
Pubmed
Cross,
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
,
Pubmed
,
Xenbase
Datta,
AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation.
1995,
Pubmed
Datta,
Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells.
1996,
Pubmed
Delcommenne,
Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.
1998,
Pubmed
Deprez,
Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades.
1997,
Pubmed
Domin,
Using structure to define the function of phosphoinositide 3-kinase family members.
1997,
Pubmed
Dudek,
Regulation of neuronal survival by the serine-threonine protein kinase Akt.
1997,
Pubmed
Franke,
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.
1995,
Pubmed
Frech,
High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity.
1997,
Pubmed
Graves,
Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells.
1993,
Pubmed
Graves,
Insulin, growth factors, and cAMP: antagonism in the signal transduction pathways.
1996,
Pubmed
Gray,
Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins.
1998,
Pubmed
Göransson,
Insulin-induced translocation of protein kinase B to the plasma membrane in rat adipocytes.
1998,
Pubmed
Harwood,
Glycogen synthase kinase 3 regulates cell fate in Dictyostelium.
1995,
Pubmed
Hordijk,
cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts.
1994,
Pubmed
Jones,
Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily.
1991,
Pubmed
Kauffmann-Zeh,
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.
1997,
Pubmed
Kohn,
Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase.
1995,
Pubmed
Kohn,
Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation.
1996,
Pubmed
Konishi,
Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27.
1997,
Pubmed
Krueger,
Calcium-stimulated phosphorylation of MAP-2 in pancreatic betaTC3-cells is mediated by Ca2+/calmodulin-dependent kinase II.
1997,
Pubmed
Kulik,
Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.
1997,
Pubmed
Matthews,
Ion channels that are directly activated by cyclic nucleotides.
1991,
Pubmed
Moule,
Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms.
1997,
Pubmed
Nikolakaki,
Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells.
1993,
Pubmed
Pap,
Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway.
1998,
Pubmed
Parvathenani,
Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3.
1998,
Pubmed
Philpott,
Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons.
1997,
Pubmed
Roskoski,
Assays of protein kinase.
1983,
Pubmed
Sable,
Involvement of the pleckstrin homology domain in the insulin-stimulated activation of protein kinase B.
1998,
Pubmed
Sable,
cAMP stimulates protein kinase B in a Wortmannin-insensitive manner.
1997,
Pubmed
Sevetson,
Increasing cAMP attenuates activation of mitogen-activated protein kinase.
1993,
Pubmed
Siegfried,
wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate.
1992,
Pubmed
Staal,
Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma.
1977,
Pubmed
Stephens,
Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.
1998,
Pubmed
Sutherland,
Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling.
1993,
Pubmed
Tanti,
Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes.
1997,
Pubmed
Ui,
Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase.
1995,
Pubmed
Virbasius,
Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain.
1996,
Pubmed
Welsh,
Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase.
1997,
Pubmed
Wijkander,
Regulation of protein kinase B in rat adipocytes by insulin, vanadate, and peroxovanadate. Membrane translocation in response to peroxovanadate.
1997,
Pubmed
Wu,
Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate.
1993,
Pubmed
Yano,
Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway.
1998,
Pubmed
van Weeren,
Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB.
1998,
Pubmed
